Federal authorities have imposed fines on two US cardiac biomarker labs for bribing doctors to get patient referrals for their programs and for providing blood samples for unnecessary testing. The companies have been also accused for collaborating with Blue Wave Healthcare consultants and offering further incentives to doctors who recommend unnecessary tests. The United States Department of Justice reported that both medical labs have been charged under the False Claims Act.
One of the cardiovascular disease screening labs, HDL (Health Diagnostics Laboratory), has been ordered to pay $47 million and the other one, Singulex Inc., has to pay $1.5 million. Both the companies have agreed to pay the fines in order to settle the civil allegations filed by the Justice Departme...
Also read: Lufthansa reaches wage agreement with pilots
15:29 Lockheed F-35 jet could cost as little as $80 million in future: Pentagon official16
22:09 Cigna demands Anthem pay $14.8 billion in lawsuit to terminate merger agreement29
13:30 Humana, Aetna abandon $37B merger21
16:53 Chemours stock and bonds rally as DuPont splits settlement of toxic chemical suits16